ArticleTrials2023

The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-label clinical trial {1}.

Mengzhuo Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.